Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Iorio

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
ACP Journal Club|December 17, 2008
Review: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancerMelina Verso, Alfonso Iorio
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population?Michael Makris, Alfonso Iorio
BMJ (Clinical Research Ed.)|March 12, 2014
Ruling out DVT using the Wells rule and a D-dimer testAlfonso Iorio, James D Douketis
Annals of Internal Medicine|June 13, 2017
Computer-Aided Systematic Review Screening Comes of AgeBrian J Hemens, Alfonso Iorio
BMJ (Clinical Research Ed.)|July 6, 2011
The association between venous thromboembolism and physical inactivity in everyday lifeJames D Douketis, Alfonso Iorio
Seminars in Thrombosis and Hemostasis|August 14, 2015
Individualizing factor replacement therapy in severe hemophiliaManuel D Carcao, Alfonso Iorio
Current Treatment Options in Cardiovascular Medicine|January 25, 2013
Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachMaura Marcucci, Alfonso Iorio, James Douketis
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three monthsSerenella Conti, Francesco Guercini, Alfonso Iorio
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Emicizumab state-of-the-art updateJohnny Mahlangu, Alfonso Iorio, Gili Kenet
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
ACP Journal Club|December 17, 2008
Review: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancerMelina Verso, Alfonso Iorio
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population?Michael Makris, Alfonso Iorio
BMJ (Clinical Research Ed.)|March 12, 2014
Ruling out DVT using the Wells rule and a D-dimer testAlfonso Iorio, James D Douketis
Annals of Internal Medicine|June 13, 2017
Computer-Aided Systematic Review Screening Comes of AgeBrian J Hemens, Alfonso Iorio
BMJ (Clinical Research Ed.)|July 6, 2011
The association between venous thromboembolism and physical inactivity in everyday lifeJames D Douketis, Alfonso Iorio
Seminars in Thrombosis and Hemostasis|August 14, 2015
Individualizing factor replacement therapy in severe hemophiliaManuel D Carcao, Alfonso Iorio
Current Treatment Options in Cardiovascular Medicine|January 25, 2013
Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachMaura Marcucci, Alfonso Iorio, James Douketis
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three monthsSerenella Conti, Francesco Guercini, Alfonso Iorio
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Emicizumab state-of-the-art updateJohnny Mahlangu, Alfonso Iorio, Gili Kenet
Pageof 31